Характеристика надмолекулярных комплексов поверхностных антигенов лимфоцитов человека

Список литературы

1. Лебедев А.Т., Масс-спектрометрия в органической химии. М., «Бином. Лаборатория знаний», 2003, с. 493.
2. Филатов А.В., Червонский А. В., Брондз Б. Д. Получение моноклональных антител к антигену Lyt-3.2, Бюлл. экспер. биол. и мед., 1984, т. 47, № 86 с. 223−226.
3. Abbas А. К., Lichtman А. Н. and Pober J. S., Cellular and Molecular Immunology, Philadelphia, W. B. Saunders Company, 2000.
4. Adams P.D., Zhang R., Pustovoitov M.V., Seeholzer S.H., Ohh M., in Protein-protein interactions: a molecular cloning manual (Golemis, E.A., and Adams, P.D., ed.) N.Y., Spring Harbor Laboratory Press, Cold Spring Harbor, 2005, p. 55−66.
5. Ajuh P., Kuster В., Panov K., Zomerdijk J.C., Mann M., Lamond A.I., Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry, EMBOJ., 2000, v. 19, p. 6569−6581.
6. Akhavan-Tafti H., DeSilva R., Sugioka K., Handley R.S., Schaap A.P., Chemiluminescent acridan phosphate labelling compounds for detection in gels, Luminescence, 2001, v. 16, p. 187−91.
7. Alexander D. R., Lymphocyte Signalling: Mechanisms, Subversion, and Manipulation. (Harnett M. M. and Rigley K. P., ed.). N.Y., John Wiley & Sons, 1997.
8. Angelisova P., Hilgert I. and Horejsi V., Association of four antigens of the tetraspans family (CD37, CD53, ТАРА- 1, and R2/C33) with MHC class II glycoproteins, Immunogenetics, 1996, v. 39, p. 249−256.
9. Baier M., Werner A., Bannert N., Metzner K. and Kurth R., HIV suppression by interleukin-16, Nature, 1995, v. 378, p. 563.
10. Baier, M., Bannert N., Werner A., Lang K. and Kurth R., Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor, PNAS, 1997, v. 94, p. 52 735 277.
11. Barger, В., Whhite, F., Pace, J., Kemper, D., Ragland, W., Estimation of molecular weight by polyacrylamide gel electrophoresis using heat stable fluorophors, Anal. Biochem. 1976, 70, 327−335.
12. Bartel P.L., Roecklein J.A., SenGupta D. Fields S., A protein linkage map of Escherichia coli bacteriophage T7, Nature Genetics, 1996, v. 12, p. 72−77.
13. Bauer A., and Kuster B., Affinity purification-mass spectrometry: Powerful tools for the characterization of protein complexes, Eur. J. Biochem., 2003, v. 270, p. 570−578.
14. Becamel C., Alonso G., Galeotti N., Demey E., Jouin P., Ullmer C., Dumuis A., Bockaert J., Marin P., Synaptic multiprotein complexes associated with 5-HT (2C) receptors: a proteomic approach, EMBOJ., 2002, v. 21, p. 2332−2342.
15. Berditchevski F., Complexes of tetraspanins with integrins: more than meets the eye, J. Cell Sci., 2001, v. 114, p. 4143^4151.
16. Berditchevski F. and Odintsova E., Characterization of Integrin-Tetraspanin Adhesion Complexes: Role of Tetraspanins in Integrin Signaling, J. Cell Biol, 1999, v. 146, p. 477−492.
17. Berditchevski F., Tolias K.F., Wong K., Carpenter C.L. and Hemler M.E., A Novel Link between Integrins, Transmembrane-4 Superfamily Proteins (CD63 and CD81), and Phosphatidylinositol 4-Kinase, J. Biol. Chem., 1997, v. 272, p. 2595−2598.
18. Berditchevski F., Zutter M.M. and Hemler M.E., Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins), Mol. Biol. Cell, 1996, v. 7, p. 193−207.
19. Bernard A., Boumsell L. The clusters of differentiation (CD) defined by the First International Workshop on Human Leucocyte Differentiation Antigens, Hum Immunol., 1984, v. 11, № 1, p. 1−10.
20. Bernhard, O.K., Sheil, M.M., Cunningham, A.L., Lateral membrane protein associations of CD4 in lymphoid cells detected by cross-linking and mass spectrometry, Biochemistry, 2004, v. 43, p. 256−264.
21. Beyers, A. D., Spruyt L. L. and Williams A. F., Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5, PNAS, 1992, v. 89, p. 2945−2949.
22. Biemann K., Scoble H.A., Characterization by tandem mass spectrometry of structural modifications in proteins, Science, 1987, v. 237, p. 992−998.
23. Bruyns E., Hendricks-Taylor L.R., Meuer S., Koretzky G.A. and Schraven B., Identification of the sites of interaction between lymphocyte phosphatase-associated phosphoprotein (LPAP) and CD45, J. Biol Chem., 1995, v. 270, p. 31 372−31 376.
24. Bradshaw J.M., Mitaxov V., and Waksman G., Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase, J. Mol. Biol., 1990, v. 293, p. 971−985.
25. Bradshaw J.M. and Waksman G., Molecular recognition by SH2 domains, Adv. Protein Chem, 2002, v. 61, p. 161−210.
26. Boucheix C. and Rubinstein E., Tetraspanins, Cell. Mol. Life Sci., 2001, v. 58, p. 11 891 205.
27. Cahir McFarland E.D., Pingel J., Thomas M. L., Definition of amino acids sufficient for plasma membrane association of CD45 and CD45-associated protein, Biochemistry, 1997, v. 36, p. 7169−7175.
28. Carter P., Smith L., Ryan M. Identification and validation of cell surface antigens for antibody targeting in oncology, Endocrine-Related Cancer, 2004, v. l 1, p. 659−687.
29. Charrin S., Naour F., Oualid M., Billard M., Faure G., Hanash S.M., Boucheix C., Rubinstein E., The Major CD9 and CD81 Molecular Partner, J. Biol Chem., 2001, v. 276, No. 17, p. 14 329−14 337.
30. Claas C., Stipp C.S., Hemler M.E., Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts, J. Biol Chem., 2001, v. 276, p. 7974−7984.
31. Cole S.R., Ashman L.K., Ey P.L., Biotinylation: an alternative to radioiodination for the identification of cell surface antigens in immunoprecipitates, Mol. Immunol., 1987, v. 24. p. 699−705.
32. Crise B. and Rose J. K., Identification of palmitoylation sites on CD4, the human immunodeficiency virus receptor, J. Biol. Chem., 1992, v. 267, p. 13 593−13 597.
33. Cruikshank W. W., Center D. M., Nisar N., Wu M., Natke B., Theodore A. C. and Kornfeld H., Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression, PNAS, 1994, v. 91, p. 5109−5113.
34. Cruikshank W. and Center D. M., Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF), Journal of Immunology, 1982, v. 128, p. 2569−2574.
35. Cullen P.J., Cozier G.E., Bantin G., and Mellor H., Modular phosphoinositide-binding domeins Their role in signaling and membrane trafficking, Curr. Biol, 2001, v. 11, p. R882-R893.
36. Daban J.R., Bartolome S., Samso M., Use of the hydrophobic probe Nile red for the fluorescent staining of protein bands in sodium dodecyl sulfate-polyacrylamide gels, Anal. Biochem., 1991, v. 199, p. 169−174.
37. Desai S., Dworecki B., Cichon E., Direct immunodetection of antigens within the precast polyacrylamide gel, Anal. Biochem., 2001, v. 297, p. 94−98.
38. Dimitrov D.S., Xiao X., Chabot D.J., Broder C.C., HIV Coreceptors, J. Membrane Biol, 1998, v. 166, p. 75−90.
39. Droit A., Poirier G.G. and Hunter J.M., Experimental and bioinformatic approaches for interrogating protein-protein interactions to determine protein function, J. Mol. Endocr., 2005, v. 34, p. 263−280.
40. Dzandu J.K., Johnson J.F., Wise G.E., Sodium dodecyl sulfate-gel electrophoresis: staining of polypeptides using heavy metal salts, Anal. Biochem., 1988, v. 174, p. 157 167.
41. Engering A. and Pieters J., Association of distinct tetraspanins with MHC class II molecules at different subcellular locations in human immature dendritic cells, Int. Immunol., 2001, v. 13, p. 127−134.
42. Fashena S.J., Serebriiskii I.G., Golemis E.A., The continued evolution of two-hybrid screening approaches in yeast: How to outwit different preys with different baits, Gene, 2000, v. 250, p. 1−14.
43. Feng Y., Broder C.C., Kennedy P.E., Berger E.A., HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor, Science, 1996, v. 272, p. 872−877.
44. Fenn J., Mann M., Meng C., Wong S., Whitehouse C., Electrospray ionisation for mass spectrometry of large biomolecules, Science, 1989, v. 246, p. 64−71.
45. Flajolet M., Rotondo G., Daviet L., Bergametti F., Inchauspe G., Tiollais P., Transy C. Legrain P., A genomic approach of the hepatitis C virus generates a protein interaction map, Gene, 2000, v. 242, p. 369−379.
46. Foti M., Phelouzat M. A., Holm A., Rasmusson B. J. and Carpentier J. L., p56Lck anchors CD4 to distinct microdomains on microvilli, PNAS, 2002, v. 99, p. 2008−2013.
47. Freeman W.M., Walker S.J. and Vrana K.E., Quantitative RT-PCR: pitfalls and potential, Biotechniques, 1999, v. 26, p. 112−122.
48. Gee S.H., Sekely S.A., Lombardo C., Kurakin A., Froehner S.C., and Kay B.K., Cyclic peptides as non-carboxyl-terminal ligands of syntrophin PDZ domains, J. Biol. Chem, 1998, v. 273, p. 21 980−21 987.
49. Ghose R., Shekhtman A., Goger M.J., Ji H., Cowburn D.A., novel, specific interaction involving the Csk SH3 domain and its natural ligand, Nature Struct. Biol, 2001, v. 8, p. 998−1004.
50. Gosling J., A decade of development in immunoassay methodology, Clin. Chem., 1990, v. 36, p. 1408−1427.
51. Graziani-Bowering G., Filion L. G., Thibault P. and Kozlowski M., CD4 is active as a signaling molecule on the human monocytic cell line Thp-1, Experimental Cell Research, 2002, v. 279, p. 141−152.
52. Guttman A., Csapo Z., Robbins D., Rapid two-dimensional analysis of proteins by ultra-thin layer gel electrophoresis, Proteomics, 2002, v. 2, p. 469−474.
53. Ha-Lee Y. M., Lee Y., Kim Y. K. and Sohn J., Cross-linking of CD4 induces cytoskeletal association of CD4 and p561ck, Experimental & Molecular Medicine, 2000, v. 32, p. 1822.
54. Hall L.R., Streuli M., Schlossman S.F., Saito H. Complete exon-intron organization of the human leukocyte common antigen (CD45) gene, J. Immunol., 1988, v. 141, p. 27 812 787.
55. Harlow E., Lane D., Antibodies. A laboratory manual, New York, Cold Spring Harbor Laboratory Press, 1988.
56. Harris B.Z., Hillier B.J., Lim W.A., Energetic Determinants of Internal Motif Recognition by PDZ Domains, Biochemistry, 2001, v. 40, p. 5921−5930.
57. Haugland R., in: Spencer, M. (Ed.), Handbook of Fluorescent Probes and Research Chemicals, Molecular Probes Inc., Eugene, OR, 1996.
58. Hemler M.E., Integrin-associated proteins, J. Cell Biol., 2001, v. 155, p. 1103−1108.
59. Hemler M.E. and Lobb R.R., The leukocyte pi integrins, Curr. Opin. Hematol., 1995, v. 2, p. 61−67.
60. Henzel W.J., Watanabe C., Stults J.T., Protein identification: The origins of peptide mass fingerprints, J. Am. Soc. Mass Spectr., 2003, v. 14, p. 931−942.
61. Hillenkamp F., Karas M., Beavis R., Chait B., Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers, Analytical Chemistry, 1991, v. 63, p. 1193−1203.
62. Hof P., Pluskey S., Dhe-Paganon S., Eck M.J., and Shoelson S.E., Crystal structure of the tyrosine phosphatase SHP-2, Cell, 1998, v. 92, p. 441−450.
63. Horvath G., Serru V., Clay D., Billard M., Boucheix C. and Rubinstein E., CD19 Is Linked to the Integrin-associated Tetraspans CD9, CD81, and CD82, J. Biol. Chem., 1998, v. 273, p. 30 537−30 543.
64. Hunt D.F., Shabanowitz J., Yates J.R. 3rd, Zhu N.Z, Russell D.H., Tandem quadrupole Fourier-transform mass spectrometry of oligopeptides and small proteins, PNAS, 1987, v. 84, p. 620−623.
65. Hunt G., Nashabeh W., Capillary electrophoresis sodium dodecyl sulfate nongel sieving analysis of a therapeutic recombinant monoclonal antibody: a biotechnology perspective, Anal Chem., 1999, v. 71, p. 2390−2397.
66. Hurley W.L., Finkelstein E., Hoist B.D., Identification of surface proteins on bovine leukocytes by a biotin-avidin protein blotting technique, J. Immunol. Meth., 1985, v. 85, p. 195−202.
67. Huse M., Eck M.J., Harrison S.C., A Zn2+ ion links the cytoplasmic tail of CD4 and the N-terminal region of Lck, J. Biol. Chem., 1998, v. 273, p. 18 729−18 733.
68. Iida N., Lokeshwar V.B., Bourguignon L.Y., Mapping the fodrin binding domain in CD45, a leukocyte membrane-associated tyrosine phosphatase, J. Biol. Chem., 1994, v. 269, p. 28 576−28 583.
69. Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M., Scully R., Qin J., Nakatani Y., Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis, Cell, 2000, v. 102, p. 463−473.
70. Ito T., Chiba T., Ozawa R., Yoshida M., Hattori M., Sakaki Y., A comprehensive two-hybrid analysis to explore the yeast proteininteractome, PNAS, 2001, v. 98, p. 45 694 574.
71. Ito T., Ota K., Kubota H., Yamaguchi Y., Chiba T., Sakuraba K., Yoshida M., Roles for the two-hybrid system in exploration of the yeast protein interactome, Molecular Cell Proteomics, 2002, v. 1, p. 561−566.
72. Jelen F., Oleksy A., Smietana K., Otlewski J., PDZ domains common players in the cell signaling, Acta Biochem. Pol., 2003, v. 50, p. 985−1017.
73. Kahne T., Ansorge S., Non-radioactive labelling and immunoprecipitation analysis of leukocyte surface proteins using different methods of protein biotinylation, J. Immunol. Meth, 1994, v. 168, p. 209−218.
74. Karas M., Hillenkamp F., Laser desorption ionisation of proteins with molecular masses exceeding 10.000 Daltons, Analytical Chemistry, 1988, v. 60, p. 2299−2301.
75. Kawakami Y. et al., Tetraspanin CD9 is a 'proteo lipid' and its interaction with o3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility, J. Biol Chem., v. 277,2002, p. 34 349−34 358.
76. Kinch M.S., Sanfridson A. and Doyle C., The protein tyrosine kinase p561ck regulates cell adhesion mediated by CD4 and major histocompatibility complex class II proteins, Journal of Experimental Medicine, 1994, v. 180, p. 1729−1739.
77. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, 1975, v. 256, № 5517, p. 495−497.
78. Kon S., Kasai K., Takahashi S., Kikuchi K., T-cell blind panel: biochemical analysis report, In Leucocyte Typing (Kishimoto T., et al. Eds.), New York. Garland Publishing. -1997, v. 6.
79. Koretzky G.A., Picus J., Thomas M.L. and Weiss A., Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway, Nature, 1990, v. 346, p. 66−68.
80. Kosower N., Kosower E., Newton G., Ranney H., Bimane fluorescent labels: labeling of normal human red cells under physiological conditions, PNAS, 1979, v. 76, p. 33 823 386.
81. Kosower, E., Kosower, N., Bromobimane probes for thiols, Methods EnzymoL, 1991, v. 251, p. 133−148.
82. Koyama S., Yu H., Dalgarno D.C., Shin T.B., Zydowsky L.D., Schreiber S.L., Structure of the PI3K SH3 domain and analysis of the SH3 family, Cell, 1993, v. 72, p. 945−952.
83. Krautwald S., IL-16 activates the SAPK signaling pathway in CD4+ macrophages, Journal of Immunology, 1998, v. 160, p. 5874−5879.
84. Kuriyan J. and Cowburn D., Modular peptide recognition domains in eukaryotic signaling, Annu. Rev. Biophys. Biomol. Struct., 1997, v. 26, p. 259−288.
85. Lane D., Using antibodies: a laboratory manual, New York, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1999.
86. Lee W-C., Lee K.H., Applications of affinity chromatography in proteomics, Analytical Biochem., 2004, v. 324, p. 1−10.
87. Levesque M.C., Haynes B.F. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression, J. Immunol., 1996, v. 156, № 4, p. 1557−1565.
88. Levy S., and Shoham T., The tetraspanin web modulates immune-signalling complexes, Nature Reviews., 2005, v. 5, p. 136−148.
89. Liebler D.C., Introduction to proteomics: tools for the new biology, New Jersey, Humana Press, 2002.
90. Lin Z., Crockett D.K., Lim M.S., Elenitoba-Johnson K.S.J., High-Throughput Analysis of Protein/Peptide Complexes by Immunoprecipitation and Automated LC-MS/MS, J. Biomol Techniques, 2003, v. 14, p. 149−155.
91. Liu Q., Berry D., Nash P., Pawson T., McGlade C.J., Li S.S., Structural basis for specific binding of the Gads SH3 domain to an RXXK motif-containing SLP-76 peptide: a novel mode of peptide recognition, Mol. Cell, 2003, v. 11, p. 471 -481.
92. Liu Y., Cruikshank W. W" O’Loughlin T., O’Reilly P., Center D. M. and Kornfeld H., Identification of a CD4 domain required for interleukin-16 binding and lymphocyte activation, J. Biol. Chem., 1999, v. 274, p. 23 387−23 395.
93. Louie R. R., King C. S., MacAuley A., Marth J. D., Perlmutter R. M., Eckhart W. and Cooper J.A., p561ck protein-tyrosine kinase is cytoskeletal and does not bind to polyomavirus middle T antigen, Journal of Virology, 1988, v. 62, p. 4673−4679.
94. Lynch G.W., Sloane A.J., Raso V., Lai A., Cunningham A.L., Direct evidence for native CD4 oligomers in lymphoid and monocytoid cells, Eur. J. Immunol., 1999, v. 29, p. 2590−2602.
95. Maddon P. J., Littman D. R., Godfrey M., Maddon D. E., Chess L. and Axel R., The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family, Cell, 1985, v. 42, p. 93−104.
96. Maecker H.T., Todd S.C. and Levy S., The tetraspanin superfamily: molecular facilitators, FASEBJ., 1997, v. 11, p. 428¹⁴².
97. Malik P., Baba E., Strominger J.L., Biotinylation of class I MHC molecules abrogates recognition by W6/32 antibody, Tissue Antigens, 1999, v. 53, p. 576−579.
98. Maniatis T., Fritsch E.F., and Sambrook J., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1982.
99. Mann M., Hendrickson R.C., Pandey A., Analysis of proteins and proteomes by mass spectrometry, Annual Review of Biochemistry, 2001, v. 70, p. 437−473.
100. Markides K., Graslund A., Mass spectrometry (MS) and nuclear magnetic resonance (NMR) applied to biological macromolecules, Advanced information on the Nobel Prize in Chemistry, 2002.
101. Marouga R., Davis S., Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology, Anal. Bioanal. Chem., 2005, v. 382, p. 669−678.
102. Mathy N. L., Bannert N., Norley S. G. and Kurth R., Cutting edge: CD4 is not required for the functional activity of IL-16, Journal of Immunology, 2000, v. 164, p. 4429−4432.
103. McCraith S., Holtzman T., Moss B., Fields S., Genome-wide analysis of Vaccinia virus protein-protein interactions, PNAS, 2000, v. 97, p. 4879−4884.
104. Medina D., Moskowitz N., Khan S., Christopher S., Germino J., Rapid purification of protein complexes from mammalian cells, Nucleic Acids Res., 2000, v. 28, No. 12, E61.
105. Meyer T., Lamberts B., Use of coomassie brilliant blue R250 for the electrophoresis of microgram quantities of parotid saliva proteins on acrylamide-gel strips, Biochim. Biophys. Acta, 1965, v. 107, p. 144−145.
106. Miao W.M., Vasile E., Lane W.S., Lawler J., CD36 associates with CD9 and integrins on human blood platelets, Blood, 2001- v. 97, p. 1689−1696.
107. Miceli M.C., Parnes J.R., Role of CD4 and CD8 in T cell activation and differentiation, Adv. Immunol., 1993, v. 53, p. 59−122.
108. Mittler R. S., Goldman S. J., Spitalny G. L. and Burakoff S. J., T-cell receptor-CD4 physical association in a murine T-cell hybridoma: induction by antigen receptor ligation, PNAS, 1989, v. 86, p. 8531−8535.
109. Morrison T., Weis J.J., and Wittwer C.T., Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification, Biotechniques, 1998, v. 24, p. 954−962.
110. Musacchio A., Noble M., Pauptit R., Wierenga R., Saraste M., Crystal structure of a Src-homology 3 (SH3) domain, Nature, 1992, v. 359, p. 851−855.
111. Naour F. L., Andre M., Greco C., Billard M., Sordat B., Emile J-F., Lanza F., Boucheix C., Rubinstein E. Profiling of the Tetraspanin Web of HumanColon Cancer Cells, Mol. Cell. Proteomics, 2006, p. 845−857.
112. Nourry C., Grant S.G., Borg J.P. PDZ domain proteins: plug and play, Sci STKE, 2003, v. 179, p. 1−7.
113. Novak T.J., Farber D., Leitenberg D., Hong S., Johnson P., Bottomly K., Isoforms of the transmembrane tyrosine phosphatase CD45 differentially affect T cell recognition, Immunity, 1994, v. 1, p. 109−119.
114. Ottinger E.A., Botfield M.C., and Shoelson S.E., Tandem SH2 domains confer high spesifisity in tyrosine kinase signaling, J. Biol. Chem., 1998, v. 273, p. 729−735.
115. Pandey A. and Mann M., Proteomics to study genes and genomes, Nature, 2000, v. 405, p. 837−846.
116. Parada N. A., Cruikshank W. W., Danis H. L., Ryan T. C. and Center D. M., IL-16-and other CD4 ligand-induced migration is dependent upon protein kinase C, Cellular Immunology, 1996, v. 168, p. 100−106.
117. Patton F.W., A thousand points of light: the application of fluorescence detection technologies to two-dimensional gel electrophoresis and proteomics, Electrophoresis, 2000, v. 21, p. 1123−1144.
118. Patton W. F., Detection thechologies in proteome analysis, J. Chromatography, 2002, v. 771, p. 3−31.
119. Pawson T., Gish G.D., and Nach P., SH2 domains, interaction modules and cellular wiring, Trends Cell Biol., 2001, v. 11, p. 504−511.
120. Pawson T., Gish G.D., SH2 and SH3 domains: from structure to function, Cell, 1992, v. 71, p. 359−362.
121. Pawson T., Nash P., Assembly of Cell Regulatory Systems Through Protein Interaction Domains, Science, 2003, v. 300, p. 445−452.
122. Pawson T. and Nash P., Protein-protein interactions define specificity in signal transduction Genes Dev., 2000, v. 14, p. 1027−1047.
123. Phizicky E.M., Fields S., Protein-Protein Interactions: Methods for Detection and Analysis, Microbiol. Rev., 1995, v. 59, No. 1, p. 94−123.
124. Piatier-Tonneau D., in Leucocyte Typing (Mason, D., at al., eds.), Oxford, Oxford University Press, 2002, p. 750−751.
125. Prasad K.V. and Rudd C.E., A Raf-1-related pi 10 polypeptide associates with the CD4-p561ck complex in T cells, Molecular & Cellular Biology, 1992, v. 12, p. 52 605 267.
126. Rain J. C, Selig L., De Reuse H., Battaglia V., Reverdy C., Simon S., Lenzen G., Petel F., Wojcik J., Schachter V., The protein-protein interaction map of Helicobacter pylori, Nature, 2001, v. 409, p. 211−215.
127. Ralph S.J., Thomas M.L., Morton C.C., Trowbridge I.S., Structural variants of human T200 glycoprotein (leukocyte-common antigen), EMBO.J., 1987, v. 6, p. 1251−1257.
128. Rappsilber J., Ajuh P., Lamond A.I. Mann M., SPF30 is an essential human splicing factor required for assembly of the U4/U5/U6 tri-small nuclear ribonucleoprotein into the spliceosome, J. Biol. Chem., 2001, v. 276, p. 31 142−31 150.
129. Rigaut G., Shevchenko A., Rutz B., Wilm M., Mann M., Seraphin B., A generic protein purification method for protein complex characterization and proteome exploration, Nat. Biotechnol, 1999, v. 17, p. 1030−1032.
130. Rogers P.R., Pilapil S., Hayakawa K., Romain P.L., Parker D.C., CD45 alternative exon expression in murine and human CD4+ T cell subsets, J. Immunol., 1992, v. 148, p. 4054−4065.
131. Rouer, E., Van Huynh T., Lavareda de Souza S., Lang M. C., Fischer S. and Benarous R., Structure of the human lck gene: differences in genomic organization within src-related genes affect only N-terminal exons, Gene, 1989, v. 84, p. 105−113.
132. Sadowski I., Stone J.C., Pawson T.A., Noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps, Mol. Cell. Biol, 1986, v.6, p. 43 964 408.
133. Sanders M., Makgoba M., Dhse D., Human naive and memory T cells, Immunol. Today, 1988, v. 9, p. 195−199.
134. Sayre P.H., Reinherz E.L., Structural invariance of T4 molecules from T cell clones of different antigen and major histocompatibility complex specificities, Eur. J. Immunol., 1985, v. 15, p. 291−295.
135. Schamel W.W.A., Reth M., Monomeric and Oligomeric Complexes of the B Cell Antigen Receptor, Immunity, 2000, v. 13, p. 5−14.
136. Schnaible V., Przybylski M., Identification of fluorescein-5'-isothiocyanate-modification sites in proteins by electrosprayionization mass spectrometry, Bioconjug. Chem, 1999, v. 10, p. 861−866.
137. Schulberth H.J., Kroell F., Leibold W., Biotinylation of cell surfaceMHC molecules: a complementary tool for the study of MHC class II polymorphism in cattle, J. Immunol. Methods., 1996, v. 189, p. 89−98.
138. Schwartz-Albiez R., Dorken B., Hofmann W. and Moldenhauer G., The B cell-associated CD37 antigen (gp40−52). Structure and subcellular expression of an extensively glycosylated glycoprotein, J. Immunol, 1988, v. 140, p. 905−914.
139. Shima T., Okumura N., Takao T., Satomi Y., Yagi T., Okada M. and Nagai K. Interaction of the SH2 domain of Fyn with a cytoskeletal protein, beta-adducin, Journal of Biological Chemistry, 2001, v. 276, p. 42 233−42 240.
140. Smith D.B., Johnson. K.S., Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione ?"-transferase, Gene, 1988, v. 67, p. 31−40.
141. Smith J.W., Hayward C.P., Warkentin T.E., Horsewood P., Kelton J.G., Investigation of human platelet alloantigens and glycoproteins using non-radioactive immunoprecipitation, J. Immunol. Methods., 1993, v. 158, p. 77−85.
142. Smith L.M., Sanders J.Z., Kaiser R.J., Hughes P., Dodd C., Connell C.R., Heiner C., Kent S.B., Hood L.E., Fluorescence detection in automated DNA sequence analysis, Nature, 1986, v. 321, p. 674−679.
143. Steinberg T.H., Haugland R.P., Singer Y.L., Applications of SYPRO orange and SYPRO red protein gel stains, Anal. Biochem., 1996, v. 239. p. 238−245.
144. Sterk L.M. et al., Association of the tetraspanin CD151 with the laminin-binding integrins a3/31, 06/31, a6/34 and «7/31 in cells in culture and in vivo, J. Cell Sci., 2002, v. 115, p. 1161−1173.
145. Stipp C.S., Orlicky D. and Hemler M.E., FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein, J. Biol. Chem., 2001, v. 276, p. 4853−4862.
146. Streuli M., Hall L.R., Saga Y., Schlossman S.F., and Saito H., Differential usage of exons generates at least five different mRNAs encoding human leucocyte common antigens, J.Exp.Med., 1987, v. 166, p. 1548−1566.
147. Stone K.L., Williams K.R. Enzymatic digestion of proteins in solution in SDS polyacrylamide gels in The protein protocols handbook: Second edition (edited by Walker J.M.) Totowa, New Jersey: Humana press, 2002, p. 511−521.
148. Takeda A., Matsuda A., Rachelle M. J., Paul R.M.J., Yaseen N.R., CD45-associated protein inhibits CD45 dimerization and up-regulates its protein tyrosine phosphatase activity, Blood, 2004, v. 103, p. 3440−3447.
149. Thomas, M. L., Positive and negative regulation of leukocyte activation by protein tyrosine phosphatases, Seminars in Immunology, 1995, v. 7, p. 279−288.
150. Thuillier L., Hivroz C., Fagard R., Andreoli C. and Mangeat P. Ligation of CD4 surface antigen induces rapid tyrosine phosphorylation of the cytoskeletal protein ezrin, Cellular Immunology, 1994, v. 156, p. 322−331.
151. Tijssen P., Practice and theory of enzyme immunoassays, Lab. Tech. Biochem. Mol. Biol, 1985, v. 15, p. 329−384.
152. Tochio H., Mok Y.K., Zhang Q., Kan H.M., Bredt D.S., Zhang M. Formation of NOS/PSD-95 PDZ dimer requires a preformed (3-finger structure from the nNOS PDZ domain, J. Mol. Biol, 2000, v. 303, p. 359−370.
153. Tourvieille B., Gorman S. D., Field E. H., Hunkapiller T. and Parnes J. R. Isolation and sequence of L3T4 complementary DNA clones: expression in T cells and brain, Science, 1986, v. 234, p. 610−614.
154. Travis G.H., Sutcliffe J.G. and Bok D., The retinal degeneration slow (rds) gene product is a photoreceptor disc membrane-associated glycoprotein, Neuron, 1991, v. 6, p. 61−70.
155. Trevillyan J.M., Lin Y., Chen S.J., Phillips C.A., Canna C. and Linna T.J., Human T lymphocytes express a protein-tyrosine kinase homologous to p56LSTRA, Biochimica et Biophysica Acta, 1986, v. 888, p. 286−295.
156. Trowbridge I.S. and Thomas M.L., CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development Annual Review of Immunology, 1994, v. 12, p. 85−116.
157. Turni L., Shaw S., Watson B., Mason D., CD guide. In: Leucocyte Typing, vol. VII Mason D., et al. (Eds.), Oxford, Oxford University Press, 2002, p. 747.
158. Uetz P. Two-hybrid arrays, Current Opinion in Chemical Biology, 2002, v.6, p. 57−62.
159. Uetz P., Giot L., Cagney G., Mansfield T.A., Judson R.S., Knight J.R., Lockshon D., Narayan V., Srinivasan M., Pochart P., A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae, Nature, 2000, v. 403, p. 623−627.
160. Unlii M., Morgan M.E., Minden J.S., Difference gel electrophoresis: a single gel method for detecting changes in protein extracts, Electrophoresis, 1997, v. 11, p. 20 712 077.
161. Van Agthoven A., Jarrossay D., Vilella R., Guy K., Schiavone E., Non-lineage antigens blind panel: biochemical analysis report. In: Leucocyte Typing, vol. VI. Kishimoto, T., et al. (Eds.), New York, Garland Publishing, 1997, p. 548.
162. Vasilescu J., Guo X. and Kast J., Identification of protein-protein interactions using in vivo cross-linking and mass spectrometry, Proteomics, 2004, v. 4, p. 3845−3854.
163. Vereb G., Matko J., Szollosi J., Cytometry of fluorescence resonance energy transfer, Meth. Cell Biol., 2004, v. 75, p. 105−152.
164. Veillette A., Bookman M.A., Horak E.M., Bolen J.B., Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the a (3 T-cell receptor, Cell, 1988, v. 55, p. 301−308.
165. Veillette A., Soussou D., Latour S., Davidson D., Gervais F.G., Interactions of CD45-associated protein with the antigen receptor signaling machinery in Tlymphocytes, J. Biol. Chem., 1999, v. 274, p. 14 392−14 399.
166. Vignali D. A., Carson R. T., Chang B., Mittler R. S. and Strominger J. L., The two membrane proximal domains of CD4 interact with the T cell receptor, Journal of Experimental Medicine, 1996, v. 183, p. 2097−2107.
167. Vignali D. A. and Vignali K. M., Profound enhancement of T cell activation mediated by the interaction between the TCR and the D3 domain of CD4, Journal of Immunology, 1999, v. 162, p. 1431−1439.
168. Waksman G., Shoelson S., Pant N., Cowburg D., and Kurian J., Binding of a high affinity phosphotyrosyl peptide in the src SH2 domain: Crystsl structures of the complexed and peptide forms, Cell, 1993, v. 72, p. 779−790.
169. Walhout A.J., Sordella R., Lu X., Hartley J.L., Temple G.F., Brasch M.A., Thierry-Mieg N., Vidal M., Protein interaction mapping in C. elegans using proteins involved in vulval development, Science, 2000, v. 287, p. 116−122.
170. Walker J.M., The protein protocols handbook, Totowa, New Jersey, 2002, p. 1146.
171. Wang J. H., Meijers R., Xiong Y., Liu J. H., Sakihama T., Zhang R., Joachimiak A. and Reinherz E. L., Crystal structure of the human CD4 N-terminal twodomain fragment complexed to a class II MHC molecule, PNAS, 2001, v. 98, p. 10 799−10 804.
172. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S. J, Qin J., BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures, Genes Dev., 2000, v. 14, p. 927−939.
173. Westermarck J., Weiss C., Saffrich R., Kast J., Musti A.M., Wessely M., Ansorge W., Seraphin B., Wilm M., Valdez B. C & Bohmann D., The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription, EMBO J., 2002, v. 21, p. 451 460.
174. Whitehouse C., Dreyer R., Yamashita M., Fenn J., Electrospray interface for liquid chromatographs and mass spectrometers, Anal. Chem., 1985, v. 57, p. 675−679.
175. Wirth P., Romano A., Staining methods in gel electrophoresis, including the use of multiple detection methods, J. Chromatogr., 1995, v. 698, p. 123−143.
176. Wood G. S., Warner N. L. and Warnke R. A., Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage, Journal of Immunology, 1983, v. 131, p. 212−216.
177. Wu H., Kwong P. D. and Hendrickson W. A. Dimeric association and segmental variability in the structure of human CD4, Nature, 1997, v. 387, p. 527−530.
178. Xiong Y., Kern P., Chang H. and Reinherz E., T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4, Journal of Biological Chemistry, 2001, v. 276, p. 5659−5667.
179. Xu Z., and Weiss A., Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms, Nat. Immunol., 2002, v. 3, p. 764−771.
180. Yamaguchi H. and Hendrickson W. A., Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation, Nature, 1996, v. 384, p. 484−489.
181. Yanez-Mo M. et al, Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with o3/31 integrin localized at endothelial lateral junctions, J. Cell Biol, v. 141, 1998, p. 791−804.
182. Yauch R.L., Kazarov A.R., Desai B., Lee R.T. and Hemler M.E., Direct Extracellular Contact between Integrin a3(3i and TM4SF Protein CD151, J. Biol. Chem., 2000, v. 275, p. 9230−9238.
183. Yunta M., Lazo P.A., Cellular Signalling Tetraspanin proteins as organisers of membrane microdomains and signalling complexes, Cellular Signalling, 2003, v. 15, p. 559−564.
184. Zaitseva M., Romantseva T., Manischewitz J., Wang J., Goucher D., Golding H., Increased CXCR4-dependent HIV-1 fusion in activated T cells: role of CD4/CXCR4 association, J. Leukoc. Biol., 2005, v. 78, p. 1306−1317.
185. Zeitlmann L., Sirim P., Kremmer E. and Kolanus W., Cloning of ACP33 as a novel intracellular ligand of CD4, Journal of Biological Chemistry, 2001, v. 276, p. 9123−9132.
186. Zhang M., Moran M., Round J., Low T.A., Patel Y.P., Tomassian T., Hernandez, J.D., Miceli M.C., CD45 signals outside of lipid rafts to promote ERK activation, synaptic raft clustering, and IL-2 production, J. Immunol., 2005, v. 174, p. 1479−1490.
187. Zhang W., Sloan-Lancaster J., Kitchen J., Trible R. P. and Samelson L. E., LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation, Cell, 1998a, v. 92, p. 83−92.
188. Zhang X.A., Bontrager A.L. and Hemler M.E., Transmembrane-4 Superfamily Proteins Associate with Activated Protein Kinase C (PKC) and Link PKC to Specific Pi Integrins, J. Biol. Chem., 2001, v. 276, p. 25 005−25 013.
189. Zhang Y., Center D. M., Wu D. M., Cruikshank W. W., Yuan J., Andrews D. W. and Kornfeld H., Processing and activation of pro-interleukin-16 by caspase-3, Journal of Biological Chemistry, 1998b, v. 273, p. 1144−1149.
190. Zimmermann P., Meerschaert K., Reekmans G., Leenaerts I., Small J. V., Vandekerckhove J., David G., Gettemans J., PIP2-PDZ domain binding controls the association of syntenin with the plasma membrane, Mol. Cell, 2002, v. 9, p. 1215−1225.
191. Zola H., Swart B., Nicholson I., et al. CD molecules human cell differentiation molecules, Blood, 2005, v. 106, № 9, p. 3123−3126.